Advertisement
Singapore markets close in 4 hours 53 minutes

  • Straits Times Index

    3,290.95
    +25.00 (+0.77%)
     

  • Nikkei

    38,223.72
    +149.74 (+0.39%)
     

  • Hang Seng

    18,852.96
    +315.15 (+1.70%)
     

  • FTSE 100

    8,381.35
    +27.30 (+0.33%)
     

  • Bitcoin USD

    62,930.55
    +1,285.57 (+2.09%)
     

  • CMC Crypto 200

    1,350.78
    +50.68 (+3.90%)
     

  • S&P 500

    5,214.08
    +26.41 (+0.51%)
     

  • Dow

    39,387.76
    +331.36 (+0.85%)
     

  • Nasdaq

    16,346.26
    +43.46 (+0.27%)
     

  • Gold

    2,359.80
    +19.50 (+0.83%)
     

  • Crude Oil

    79.80
    +0.54 (+0.68%)
     

  • 10-Yr Bond

    4.4490
    -0.0430 (-0.96%)
     

  • FTSE Bursa Malaysia

    1,602.11
    +0.89 (+0.06%)
     

  • Jakarta Composite Index

    7,088.79
    -34.81 (-0.49%)
     

  • PSE Index

    6,567.84
    +25.38 (+0.39%)
     

Company News For Jun 20, 2018

Zacks Equity Research
Updated
Ross Stores (ROST) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

  • AT&T Inc.’s T shares increased 0.6% after the company announced that there will be fewer commercials, personalized programming and smaller channel bundles following its acquisition of Time Warner

  • Shares of Foundation Medicine, Inc. FMI surged 28.5% on news that Swiss drug behemoth Roche was buying out the company for $2.4 billion

  • Cotiviti Holdings, Inc.’s COTV shares increased 10.3% after Verscend Technologies Inc agreed to buy the company for $4.9 billion

  • Shares of Sarepta Therapeutics, Inc. SRPT rose 36.8% after the company announced positive results from Phase 1/2 test on its microdystrophin gene therapy for Duchenne muscular dystrophy, or DMD


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Foundation Medicine, Inc. (FMI) : Free Stock Analysis Report
 
AT&T Inc. (T) : Free Stock Analysis Report
 
Sarepta Therapeutics, Inc. (SRPT) : Free Stock Analysis Report
 
Cotiviti Holdings, Inc. (COTV) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research